Burgess D B
Ophthalmology. 1986 Jul;93(7):967-8. doi: 10.1016/s0161-6420(86)33653-4.
The Macular Photocoagulation Study (MPS) is a multi-center clinical trial supported by the National Eye Institute whose purpose is to assess argon laser photocoagulation as a treatment for choroidal neovascular membranes (NVMs) that do not involve the fovea. The MPS documented that in patients with ocular histoplasmosis syndrome argon laser photocoagulation in comparison with no treatment can reduce the risk of severe visual loss from 46 to 13% in the first two years. Accordingly, patients with ocular histoplasmosis and NVMs outside the fovea are advised to undergo prompt treatment with argon laser photocoagulation.
黄斑光凝研究（MPS）是一项由美国国立眼科研究所支持的多中心临床试验，其目的是评估氩激光光凝术作为一种治疗不涉及黄斑中心凹的脉络膜新生血管膜（NVM）的方法。MPS记录表明，对于患有眼组织胞浆菌病综合征的患者，与不进行治疗相比，氩激光光凝术可在头两年将严重视力丧失的风险从46%降低至13%。因此，建议患有眼组织胞浆菌病且黄斑中心凹以外有NVM的患者立即接受氩激光光凝治疗。
